Does FOSTAMATINIB Cause Off label use? 680 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 680 reports of Off label use have been filed in association with FOSTAMATINIB (TAVALISSE). This represents 10.6% of all adverse event reports for FOSTAMATINIB.
680
Reports of Off label use with FOSTAMATINIB
10.6%
of all FOSTAMATINIB reports
42
Deaths
151
Hospitalizations
How Dangerous Is Off label use From FOSTAMATINIB?
Of the 680 reports, 42 (6.2%) resulted in death, 151 (22.2%) required hospitalization, and 1 (0.1%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FOSTAMATINIB. However, 680 reports have been filed with the FAERS database.
What Other Side Effects Does FOSTAMATINIB Cause?
Diarrhoea (904)
Platelet count decreased (804)
Product dose omission issue (711)
Hospitalisation (403)
Platelet count (375)
Drug ineffective (340)
Fatigue (332)
Blood pressure increased (314)
Death (307)
Headache (237)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which FOSTAMATINIB Alternatives Have Lower Off label use Risk?
FOSTAMATINIB vs FOSTEMSAVIR TROMETHAMINE
FOSTAMATINIB vs FOTEMUSTINE
FOSTAMATINIB vs FRAMYCETIN
FOSTAMATINIB vs FREMANEZUMAB
FOSTAMATINIB vs FREMANEZUMAB-VFRM